Cargando…
Community guidelines for GPCR ligand bias: IUPHAR review 32
GPCRs modulate a plethora of physiological processes and mediate the effects of one‐third of FDA‐approved drugs. Depending on which ligand activates a receptor, it can engage different intracellular transducers. This ‘biased signalling’ paradigm requires that we now characterize physiological signal...
Autores principales: | Kolb, Peter, Kenakin, Terry, Alexander, Stephen P. H., Bermudez, Marcel, Bohn, Laura M., Breinholt, Christian S., Bouvier, Michel, Hill, Stephen J., Kostenis, Evi, Martemyanov, Kirill A., Neubig, Rick R., Onaran, H. Ongun, Rajagopal, Sudarshan, Roth, Bryan L., Selent, Jana, Shukla, Arun K., Sommer, Martha E., Gloriam, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612872/ https://www.ncbi.nlm.nih.gov/pubmed/35106752 http://dx.doi.org/10.1111/bph.15811 |
Ejemplares similares
-
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels
por: Harmar, Anthony J., et al.
Publicado: (2009) -
Pharmacogenomics of GPCR Drug Targets
por: Hauser, Alexander S., et al.
Publicado: (2018) -
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
por: Armstrong, Jane F, et al.
Publicado: (2020) -
The IUPHAR Pharmacology Education Project
por: Faccenda, Elena, et al.
Publicado: (2018) -
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology
por: Harding, Simon D., et al.
Publicado: (2020)